论文信息 - Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. - 字舞流文

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

A. Gadducci | S. Pignata | R. Biamonte | G. Scambia | G. Ferrandina | D. Lorusso | S. Greggi | S. Tateo | L. Manzione | G. Vagno | F. Ferraù | G. di Vagno | Giovanni Scambia